To better understand the FDAs perspective on GLP-1 compounding, you can read: The FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss The FDAs Policies for Compounders As National GLP-1 Supply Begins To Stabilize The FDAs Guidance on Drug Products That Are Essentially Copies For consistent results and safety, the best GLP-1 for weight loss is an FDA-approved version from a reliable source
Vitamin B12 deficiency is more commonly associated with long-term metformin use or restrictive dietary patterns than with GLP-1-based therapy itself, and supplementation should be guided by assessment rather than assumed
A clinician should review the full medication list, pregnancy plans, gastrointestinal disease history, and prior pancreatitis or gallbladder issues
A study published in May 2024 found that men with obesity who were taking semaglutide, the active ingredient in Ozempic and Wegovy, were actually at a slightly higher risk of erectile dysfunction than men with obesity who werent taking the drug
Enjoy a FREE 2-week trial of Juvents Micro-Impact Platform